← Association for Accessible Medicines
FDANonrulemakingFDA-2018-D-1067

Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act

RIN
—
Last modified
Sep 7, 2022
Comment window
closed 3086d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between May 25, 2018 and May 25, 2018. 2 other organizations filed here. The comment window closed 3086d ago.

What Association for Accessible Medicines filed (1)

May 25, 2018· Comment from Association for Accessible Medicines (AAM)· FDA-2018-D-1067-0045

Comments from The Association for Accessible Medicines (AAM) on behalf of a strong consensus of our member companies, regarding Docket FDA-2018-D-1067: Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug and Cosmetic Act.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (2)

See everyone who commented →